In the name of science: Ethical violations in the ECHO randomised trial

References

• Armstrong, M. D. (2017). The ANC’s medical trial run: The anti-apartheid medical service in exile, 1964–1990 (Unpublished doctoral dissertation). Carleton University, Ottawa, Ontario.
   Google Scholar
• Baeten, J. (2016, July 21). Update on the ECHO randomised trial on HIV acquisition among users of different hormonal contraceptive (HC) methods. (Slides). Code THSA0904. Paper presented at the AIDS 2016 conference in the panel, Hormonal Contraception and HIV: A Review of the Science and Research, and Their Implications for Research, Programme and Policy. Retrieved from http://programme.aids2016.org/Programme/Session/41
   Google Scholar
• Bank, D., & Buckman, R. (2002, May 17). Gates Foundation buys stakes in drug makers. The Wall Street Journal. Retrieved from https://www.wsj.com/articles/SB1021577629748680000
   Google Scholar
• Bayer. (n.d). 27 million contraceptive implants in six years. Retrieved from http://pharma.bayer.com/en/commitment-responsibility/family-planning/implant-initiative/
   Google Scholar
• Boozang, K. M., Coleman, C., Miller, T. E., Greenwood, K., Gutmann, V., Handler-Hutchinson, S., & Finizio, C. (2009). Conflicts of interest in clinical trial recruitment & enrollment: A call for increased oversight. Newark, NJ: The Center for Health & Pharmaceutical Law & Policy, Seton Hall University School of Law.
   Google Scholar
• Brown, J. G. (2000). Recruiting human subjects: Sample guidelines for practice. Boston, MA: Department of Health and Human Services, Office of Inspector General. Retrieved from https://oig.hhs.gov/oei/reports/oei-01-97-00196.pdf
   Google Scholar
• Butler, A. R., Smith, J. A., Polis, C. B., Gregson, S., Stanton, D., & Hallett, T. B. (2013). Modelling the global competing risks of a potential interaction between injectable hormonal contraception and HIV risk. Aids (London, England), 27(1), 105–113. doi: 10.1097/QAD.0b013e32835a5a52
   PubMed Web of Science ®Google Scholar
• Cates, W., & for the Evidence for Contraceptive Options and HIV Outcomes (ECHO) Consortium. (2014). Research on hormonal contraception and HIV. The Lancet, 383(9914), 303–304. doi: 10.1016/S0140-6736(14)60097-0
   PubMedGoogle Scholar
• ClinicalTrials.gov. (n.d.a). Disclaimer. Retrieved from https://clinicaltrials.gov/ct2/about-site/disclaimer
   Google Scholar
• ClinicalTrials.gov. (n.d.b). The evidence for contraceptive options and HIV outcomes trial (ECHO). Retrieved from https://clinicaltrials.gov/ct2/show/record/NCT02550067
   Google Scholar
• Council for International Organizations of Medical Sciences. (2016). International ethical guidelines for health-related research involving humans (4th ed). Geneva: Author.
   Google Scholar
• Deaton, A., & Cartwright, N. (2018). Understanding and misunderstanding randomized controlled trials. Social Science & Medicine, 210, 2–21. https://doi.org/10.1016/j.socscimed.2017.12.005
   PubMed Web of Science ®Google Scholar
• ECHO Consortium. (2017, March 3). The Evidence for contraceptive options and HIV outcomes: Supplementary File 1: ECHO trial Protocol. Version 5.0.
   Google Scholar
• ECHO Consortium. (n.d.a). Study Design. Retrieved from http://echo-consortium.com/study-design/
   Google Scholar
• ECHO Consortium. (n.d.b). Retrieved from http://echo-consortium.com/wp-content/uploads/2018/09/map-of-sites-2018-1.png
   Google Scholar
• Edwards, S. J. L., Lilford, R. J., & Hewison, J. (1998). The ethics of randomised controlled trials from the perspectives of patients, the public, and healthcare professionals. British Medical Journal, 317(7167), 1209–1212. doi: 10.1136/bmj.317.7167.1209
   PubMed Web of Science ®Google Scholar
• English Oxford Living Dictionaries. (n.d.). Retrieved from https://en.oxforddictionaries.com/definition/believe
   Google Scholar
• European Medicines Agency. (2004). ICH topic E 2 D: Post approval safety data management. Retrieved from https://www.ema.europa.eu/en/documents/scientific-guideline/international-conference-harmonisation-technical-requirements-registration-pharmaceuticals-human-use_en-12.pdf
   Google Scholar
• Feldblum, P. J., Caraway, J., Bahamondes, L., El-Shafei, M., Quan, H. D., Morales, E., … Condon, S. (2005). Randomized assignment to copper IUD or depot-medroxyprogesterone acetate: Feasibility of enrollment, continuation and disease ascertainment. Contraception, 72, 187–191. doi: 10.1016/j.contraception.2005.03.006
   PubMed Web of Science ®Google Scholar
• FHI 360 Study #523201. (2017a, 5 April). Echo template: enrolment informed consent Form V6.0.
   Google Scholar
• FHI 360 Study #523201. (2017b, 5 April). Echo template: screening informed consent Form V6.0.
   Google Scholar
• Forder, P. M., Gebski, V. J., & Keech, A. C. (2005). Allocation concealment and blinding: When ignorance is bliss. The Medical Journal of Australia, 182(2), 87–89. https://doi.org/10.5694/j.1326-5377.2005.tb06584.x
   PubMed Web of Science ®Google Scholar
• Hapgood, J. P., Kaushic, C., & Hel, Z. (2018). Hormonal contraception and HIV-1 acquisition: Biological mechanisms. Endocrine Reviews, 39(1), 36–78. doi: 10.1210/er.2017-00103
   PubMed Web of Science ®Google Scholar
• Hickey, M., Marino, J. L., & Tachedjian, G. (2016). Critical review: Mechanisms of HIV transmission in depo-provera users: The likely role of hypoestrogenism. Journal of Acquired Immune Deficiency Syndromes, 71(1), 1–7. doi:10.1097/QAI.0000000000000805.
   PubMed Web of Science ®Google Scholar
• Hofmeyr, G. J., Morrison, C. S., Baeten, J. M., Chipato, T., Donnell, D., Gichangi, P., … Taylor, D. (2018). Rationale and design of a multi-center, open-label, randomised clinical trial comparing HIV incidence and contraceptive benefits in women using three commonly-used contraceptive methods (the ECHO study) [version2; referees 2 approved]. Gates Open Research, 1, 17. doi: 10.12688/gatesopenres.12775.2
   PubMedGoogle Scholar
• Human Reproduction Programme. (2018). The evidence for contraceptive options and HIV outcomes (ECHO) Trial: current project brief. Retrieved from http://www.who.int/reproductivehealth/projects/ECHO.pdf
   Google Scholar
• Jain, A. K. (2012). Hormonal contraception and HIV acquisition risk: Implications for individual users and public policies. Contraception, 86(6), 645–652. doi: 10.1016/j.contraception.2012.03.008
   PubMed Web of Science ®Google Scholar
• Jepson, M., Elliott, D., Conefrey, C., Wade, J., Rooshenas, L., Wilson, C., … Stallard, N. (2018). An observational study showed that explaining randomization using gambling-related metaphors and computer-agency descriptions impeded randomized clinical trial recruitment. Journal of Clinical Epidemiology, 99, 75–83. doi: 10.1016/j.jclinepi.2018.02.018
   PubMed Web of Science ®Google Scholar
• Kahan, B. C., Rehal, S., & Cro, S. (2015). Risk of selection bias in randomised trials. Trials, 16, 405. doi: 10.1186/s13063-015-0920-x
   PubMed Web of Science ®Google Scholar
• Karlberg, J. P. E., & Speers, M. A. (Eds.). (2010). Reviewing clinical trials: A guide for the ethics committee. Hong Kong: Karlberg, Johan Petter Einar.
   Google Scholar
• Martin, H. L., Nyange, P. M., Richardson, B. A., Lavreys, L., Mandaliya, K., Jackson, D. J., … Kreiss, J. (1998). Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1. The Journal of Infectious Diseases, 178(4), 1053–1059. doi:10.1086/515654.
   PubMed Web of Science ®Google Scholar
• Moodley, K., Pather, M., & Myer, L. (2005). Informed consent and participant perceptions of influenza vaccine trials in South Africa. Journal of Medical Ethics, 31(12), 727–732. doi: 10.1136/jme.2004.009910
   PubMed Web of Science ®Google Scholar
• Mosher, H. I., Moorthi, G., Li, J., & Weeks, M. R. (2015). A qualitative analysis of peer recruitment pressures in respondent driven sampling: Are risks above the ethical limit? International Journal of Drug Policy, 26(9), 832–842. doi: 10.1016/j.drugpo.2015.05.027
   PubMed Web of Science ®Google Scholar
• Mostad, S. B., Overbaugh, J., DeVange, D. M., Welch, M. J., Chohan, B., Mandaliya, K., … Kreiss, J. K. (1997). Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina’. The Lancet, 350(9082), 922–927. doi: 10.1016/S0140-6736(97)04240-2
   PubMed Web of Science ®Google Scholar
• MRC Clinical Trials Unit. (n.d.). What is a randomised clinical trial? Retrieved from https://www.ctu.mrc.ac.uk/patients-public/about-clinical-trials/what-is-a-randomised-clinical-trial/
   Google Scholar
• Multinational Monitor. (1985). The Case against Depo-Provera: problems in the US. 6 (2&3). Retrieved from https://www.multinationalmonitor.org/hyper/issues/1985/02/problems-us.html
   Google Scholar
• Nardini, C. (2014). Ethics of clinical trial. Ecancer Medical Science, 8, 387. https://doi.org/10.3332/ecancer.2014.387
   PubMedGoogle Scholar
• Office of the Human Research Protection Program. (2019). Guidance and procedure: Recruitment and screening methods and materials. Los Angeles, CA: University of California, (UCLA). Retrieved from http://ora.research.ucla.edu/OHRPP/Documents/Policy/5/Recruitment.pdf
   Google Scholar
• Parliament of India. (2013). Alleged irregularities in the conduct of studies using human papilloma virus (HPV) vaccine by Path in India. Seventy second report. New Delhi: Rajya Sabha Secretariat. Retrieved from http://164.100.47.5/newcommittee/reports/EnglishCommittees/Committee%20on%20Health%20and%20Family%20Welfare/72.pdf
   Google Scholar
• Pettifor, A. E. (n.d.). Curriculum vitae. Retrieved from http://www.cpc.unc.edu/people/cv/apettif.pdf
   Google Scholar
• Pfizer. (2014, 13 November). Novel agreement expands access to Pfizer’s contraceptive, Sayana® Press, for women most in need in the world’s poorest countries. Retrieved from https://www.pfizer.com/news/press-release/press-release-detail/novel_agreement_expands_access_to_pfizer_s_contraceptive_sayana_press_for_women_most_in_need_in_the_world_s_poorest_countries
   Google Scholar
• Pfizer. (2016, 19 October). Pfizer awarded grant to evaluate vaccine to protect newborns against Group B streptococcus infection. Retrieved from https://www.pfizer.com/news/press-release/press-release-detail/pfizer_awarded_grant_to_evaluate_vaccine_to_protect_newborns_against_group_b_streptococcus_infection-0 detail/pfizer_awarded_grant_to_evaluate_vaccine_to_protect_newborns_against_group_b_streptococcus_infection-0
   Google Scholar
• Pfizer Canada Inc. (2018). Product monograph, including patient medication information: DEPO-PROVERA. Quebec: Pfizer Canada Inc. Retrieved from https://www.pfizer.ca/sites/g/files/g10050796/f/201803/DEPO-PROVERA_PM_E_210121_13Feb2018.pdf
   Google Scholar
• Polis, C. B., Curtis, K. M., Hannaford, P. C., Phillips, S. J., Chipato, T., Kiarie, J. N., … Steyn, P. S. (2016). An updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women. Aids (London, England), 30(17), 2665–2683. doi: 10.1097/QAD.0000000000001228
   PubMed Web of Science ®Google Scholar
• Potts, M., & Paxman, J. M. (1984). Depo-Provera–ethical issues in its testing and distribution. Journal of Medical Ethics, 10(1), 9–20. doi: 10.1136/jme.10.1.9
   PubMed Web of Science ®Google Scholar
• Ralph, L. J., McCoy, S. I., Hallett, T., & Padian, N. (2013). Next steps for research on hormonal contraception and HIV. The Lancet, 382(9903), 1467–1469. https://doi.org/10.1016/S0140-6736(13)61420-8
   PubMed Web of Science ®Google Scholar
• Ralph, L. J., McCoy, S. I., Shiu, K., & Padian, N. S. (2015). Hormonal contraceptive use and women’s risk of HIV acquisition: A meta-analysis of observational studies. The Lancet Infectious Diseases, 15(2), 181–189. https://doi.org/10.1016/S1473-3099(14)71052-7
   PubMed Web of Science ®Google Scholar
• Rees, H., & ECHO Consortium. (2014). DMPA and HIV: Why we need a trial. Contraception, 90(4), 354–356. doi: 10.1016/j.contraception.2014.08.007
   PubMed Web of Science ®Google Scholar
• Rivera, R., & Borasky, D. (2009). Research ethics training curriculum (2nd ed.). Research Triangle Park, NC: Family Health International.
   Google Scholar
• Saez, C. (2017, 29 January). Is Gates Foundation, WHO’s biggest funder, ineligible to Join WHO? Intellectual Property Watch. Retrieved from https://www.ip-watch.org/2017/01/29/gates-foundation-whos-biggest-private-funder-ineligible-join/
   Google Scholar
• Sathyamala, C. (1998). Hazardous contraceptives and the right to life. Journal of the Indian Law Institute, 40(1/4), 174–199. Retrieved from http://www.jstor.org/stable/43953316
   Google Scholar
• Sathyamala, C. (2000). An epidemiological review of the injectable contraceptive, Depo-Provera. Pune: Medico Friend Circle; and Mumbai: Forum for Women’s Health. Retrieved from http://www.mfcindia.org/main/Publications/Sathyamala_Epidemiological_review_depo_provera.pdf
   Google Scholar
• Simon, C., & Mosavel, M. (2010). Community members as recruiters of human subjects: Ethical considerations. The American Journal of Bioethics, 10(3), 3–11. doi: 10.1080/15265160903585578
   PubMed Web of Science ®Google Scholar
• Tsui, A. O., Brown, W., & Li, Q. (2017). Contraceptive practice in Sub-Saharan Africa. Population and Development Review, 43(Suppl 1), 166–191. doi: 10.1111/padr.12051
   PubMed Web of Science ®Google Scholar
• UNFPA. (2017). UNFPA supplies annual report 2017. New York: UNFPA Commodity Security Branch. Retrieved from https://www.unfpa.org/unfpa-supplies-annual-report-2017
   Google Scholar
• Ungchusak, K., Rehle, T., Thammapornpilap, P., Spiegelman, D., Brinkmann, U., & Siraprapasiri, T. (1996). Determinants of HIV infection among female commercial sex workers in northeastern Thailand: Results from a longitudinal study. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 12(5), 500–507. doi: 10.1097/00042560-199608150-00010
   PubMedGoogle Scholar
• U.S. Agency for International Development (USAID). (2017). Overview of contraceptive and condom shipments, FY 2016. Washington, D.C.: John Snow, Inc. for USAID. Retrieved from https://www.usaid.gov/sites/default/files/documents/1864/C-C_FY16.pdf
   Google Scholar
• US Department of Health and Human Services [Office for Human Research Protections]. (n.d.). Informed Consent FAQs: what is informed consent and when, why, and how must it be obtained? Retrieved from https://www.hhs.gov/ohrp/regulations-and-policy/guidance/faq/informed-consent/index.html
   Google Scholar
• US Food and Drug Administration. (2018). Title 21—Food and Drugs. Chapter I—Food and Drug Administration, Department of Health and Human Services. Subchapter D—Drugs for human use. Retrieved from https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr=312.32
   Google Scholar
• Vermund, S. H. (2015, February). Curriculum vitae. Retrieved from https://www.vumc.org/health-policy/files/health-policy/cv/Vermund_CV20032015.pdf
   Google Scholar
• Wemos. (2017). Clinical trials in Africa: The cases of Egypt, Kenya, Zimbabwe and South Africa. Amsterdam: Wemos Foundation. Retrieved from https://www.wemos.nl/wp-content/uploads/2017/07/JH_Wemos_Clinical-Trials_v5_def.pdf
   Google Scholar
• WHO Regional Office for Africa. (2012). Addressing the challenge of women’s health in Africa. A summary of the report of the commission on women’s health in the African region. Brazzaville: Author. Retrieved from https://www.afro.who.int/sites/default/files/2017-06/report-of-the-commission-on-womens-health-in-the-african-region-who_acsummary-comp.pdf
   Google Scholar
• WHO Regional Office for Africa. (2018). The state of health in the WHO African region: An analysis of the status of health, health services and health systems in the context of the sustainable development goals. Brazzaville: Author. Retrieved from https://www.afro.who.int/sites/default/files/sessions/documents/State%20of%20health%20in%20the%20African%20Region.pdf
   Google Scholar
• World Health Organization. (2012). Hormonal contraception and HIV; technical statement. WHO/RHR/12.08. Geneva: Author. Retrieved from https://www.who.int/reproductivehealth/topics/family_planning/Hormonal_contraception_and_HIV.pdf
   Google Scholar
• World Health Organization. (2017a). Hormonal contraceptive eligibility for women at high risk of HIV: Guidance statement. Geneva: Author. Retrieved from https://apps.who.int/iris/bitstream/handle/10665/254662/WHO-RHR-17.04-eng.pdf;jsessionid=A5F016A0FA6B1E5D264E8115FC65C82B?sequence=1
   Google Scholar
• World Health Organization. (2017b, February). Hormonal contraceptive eligibility for women at high risk of HIV: Frequently asked questions. Retrieved from http://www.who.int/reproductivehealth/faqs-hormonal-contraceptive-hiv/en/
   Google Scholar
• World Medical Association. (1964). WMA declaration of Helsinki –Ethical principles for medical research involving human subjects. Amended 64th WMA General Assembly, Fortaleza, Brazil, October 2013. Retrieved from https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/
   Google Scholar